When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Pityriasis lichenoides

Última revisão: 18 Aug 2025
Última atualização: 10 Dec 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • acute to subacute recurrent skin eruption
  • polymorphic, generalized, nonpruritic skin eruption
Detalhes completos

Outros fatores diagnósticos

  • scars or pigment changes
  • immunosuppression
  • recent illness
  • family history of pityriasis lichenoides
  • headache
  • myalgias/arthralgias
  • malaise
  • burning/pruritus
  • multiorgan failure
Detalhes completos

Fatores de risco

  • childhood to early adult age
  • male sex
  • HIV
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • dermoscopy
  • skin biopsy
Detalhes completos

Investigações a serem consideradas

  • antistreptolysin titers
  • Epstein-Barr virus IgM/IgG viral capsid antigen and nuclear antigen antibody
  • monospot or heterophil antibody test
  • hepatitis B surface antigen, antisurface antibody, and anticore IgM
  • hepatitis C virus antibody
  • HIV screening
  • rapid plasma reagin
  • throat cultures
  • toxoplasma Sabin-Feldman dye test, indirect immunofluorescence/hemagglutination
  • erythrocyte sedimentation rate
  • CRP
  • serum LDH
  • WBC count
  • serum albumin
Detalhes completos

Algoritmo de tratamento

CONTÍNUA

mild to moderate disease

severe disease or treatment resistance

Colaboradores

Autores

Amy Musiek, MD

Professor of Dermatology

Division of Dermatology

Washington University School of Medicine in St. Louis

St. Louis

MO

Declarações

AM is a paid lecturer in cutaneous T-cell lymphoma for Dermatology Week, is the author of the UpToDate article on Pityriasis lichenoides chronica, and is an investigator for multiple industry sponsored studies all unrelated to pityriasis lichenoides.

Agradecimentos

Dr Amy Musiek would like to gratefully acknowledge Dr Amer Khachemoune and Dr Marianna Blyumin-Karasik, previous contributors to this topic.

Declarações

AK and MB-K declare that they have no competing interests.

Revisores

Andrew D. Lee, MD

Resident

Department of Dermatology

Wake Forest University School of Medicine

Winston-Salem

NC

Declarações

ADL declares that he has no competing interests.

Abdulhafez Selim, MD

Assistant Professor

King Fahd University of Petroleum and Minerals

Dhahran

Saudi Arabia

Declarações

AS declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment review. Am J Clin Dermatol. 2007;8(1):29-36. Resumo

Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006 Oct;55(4):557-72; quiz 573-6. Resumo

Bellinato F, Maurelli M, Gisondi P, et al. A systematic review of treatments for pityriasis lichenoides. J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2039-49. Resumo

Jung F, Sibbald C, Bohdanowicz M, et al. Systematic review of the efficacies and adverse effects of treatments for pityriasis lichenoides. Br J Dermatol. 2020 Dec;183(6):1026-32. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Pityriasis lichenoides images
  • Diagnósticos diferenciais

    • Lymphomatoid papulosis
    • Guttate psoriasis
    • Drug eruption
    Mais Diagnósticos diferenciais
  • Folhetos informativos para os pacientes

    Psoriasis: what is it?

    Psoriasis: what are the treatment options?

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal